The Challenge of Atropisomerism in Drug Discovery

Jonathan Clayden, Wesley J. Moran, Paul J. Edwards, Steven R. Laplante

Research output: Contribution to journalArticlepeer-review

583 Citations (Scopus)


A twist in the tale: Recent reports have highlighted solutions to the problems encountered when drug candidates exist as slowly interconverting conformers or atropisomers (see scheme). This Minireview brings together the various strategies that have been adopted and proposes a general approach to handling an aspect of stereochemistry which has received little attention from drug regulatory agencies.

Original languageEnglish
Pages (from-to)6398-6401
Number of pages4
JournalAngewandte Chemie - International Edition
Issue number35
Early online date27 Jul 2009
Publication statusPublished - 17 Aug 2009
Externally publishedYes


Dive into the research topics of 'The Challenge of Atropisomerism in Drug Discovery'. Together they form a unique fingerprint.

Cite this